Bluejay Diagnostics Statistics
Total Valuation
BJDX has a market cap or net worth of $1.14 million. The enterprise value is -$4.36 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BJDX has 330,962 shares outstanding.
| Current Share Class | 330,962 |
| Shares Outstanding | 330,962 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 7.45% |
| Float | 329,853 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.17 |
| P/TBV Ratio | 0.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.26, with a Debt / Equity ratio of 0.04.
| Current Ratio | 6.26 |
| Quick Ratio | 5.49 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.82 |
Financial Efficiency
Return on equity (ROE) is -138.78% and return on invested capital (ROIC) is -77.37%.
| Return on Equity (ROE) | -138.78% |
| Return on Assets (ROA) | -60.78% |
| Return on Capital (ROIC) | -77.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$858,855 |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.74% in the last 52 weeks. The beta is 0.73, so BJDX's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -99.74% |
| 50-Day Moving Average | 5.66 |
| 200-Day Moving Average | 130.81 |
| Relative Strength Index (RSI) | 39.40 |
| Average Volume (20 Days) | 959,149 |
Short Selling Information
The latest short interest is 21,061, so 6.36% of the outstanding shares have been sold short.
| Short Interest | 21,061 |
| Short Previous Month | 159,885 |
| Short % of Shares Out | 6.36% |
| Short % of Float | 6.38% |
| Short Ratio (days to cover) | 0.09 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.07M |
| Pretax Income | -9.74M |
| Net Income | -8.59M |
| EBITDA | -7.99M |
| EBIT | -8.07M |
| Earnings Per Share (EPS) | -$163.76 |
Full Income StatementBalance Sheet
The company has $5.76 million in cash and $255,989 in debt, giving a net cash position of $5.50 million or $16.62 per share.
| Cash & Cash Equivalents | 5.76M |
| Total Debt | 255,989 |
| Net Cash | 5.50M |
| Net Cash Per Share | $16.62 |
| Equity (Book Value) | 7.16M |
| Book Value Per Share | 20.09 |
| Working Capital | 5.52M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.86 million and capital expenditures -$393,552, giving a free cash flow of -$9.25 million.
| Operating Cash Flow | -8.86M |
| Capital Expenditures | -393,552 |
| Free Cash Flow | -9.25M |
| FCF Per Share | -$27.96 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |